Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group

Sadeleştirilmiş öğe sayfası
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorSendur, Mehmet Ali Nahit
dc.contributor.authorCangir, Ayten Kayi
dc.contributor.authorFirat, Pinar
dc.contributor.authorGoker, Erdem
dc.contributor.authorKilickap, Saadettin
dc.contributor.authorOyan, Basak
dc.contributor.authorOz, Aysim Buge
dc.contributor.authorOzdemir, Feyyaz
dc.contributor.authorOzyigit, Gokhan
dc.date.accessioned2025-10-16T15:14:12Z
dc.date.issued2023
dc.identifier.doi10.1016/j.currproblcancer.2023.101017
dc.identifier.otherWOS:001125100500001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6092
dc.publisherMOSBY-ELSEVIER
dc.sourceCURRENT PROBLEMS IN CANCER
dc.subjectBiomarker
dc.subjectCancer
dc.subjectChemotherapy
dc.subjectImmune checkpoint inhibitor
dc.subjectImmunotherapy
dc.subjectPleural mesothelioma
dc.titleEstablished and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS